Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) Debt to Equity (2020 - 2021)

Pharma-Bio Serv (PBSV) has disclosed Debt to Equity for 2 consecutive years, with $0.09 as the latest value for Q2 2021.

  • For the quarter ending Q2 2021, Debt to Equity rose 1.17% year-over-year to $0.09, compared with a TTM value of $0.09 through Apr 2021, up 1.17%, and an annual FY2020 reading of $0.09, changed N/A over the prior year.
  • Debt to Equity was $0.09 for Q2 2021 at Pharma-Bio Serv, down from $0.09 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.09 in Q1 2021 and bottomed at $0.09 in Q4 2020.